• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症中的脑脊液:免疫球蛋白、白细胞与临床特征之间的关系

Cerebrospinal fluid in multiple sclerosis: relationships between immunoglobulins, leucocytes and clinical features.

作者信息

Walker R W, Thompson E J, McDonald W I

出版信息

J Neurol. 1985;232(4):250-9. doi: 10.1007/BF00313789.

DOI:10.1007/BF00313789
PMID:2413178
Abstract

Cerebrospinal fluid (CSF) from 120 patients with multiple sclerosis was analyzed by polyacrylamide gel electrophoresis, as well as routine laboratory microscopy and assays of total protein and immunoglobulin G (IgG). Negative correlations were found between leucocyte counts and patient age, duration of disease and time from last clinical relapse. There was a positive correlation between the leucocyte count and amount of gammaglobulin. A correlation between gammaglobulin content and degree of disability was found. With increasing duration, the gammaglobulin concentration rose only if there was increasing disability. In terms of correlations with clinical features, differences existed depending on whether IgG was assayed immunologically or by electrophoresis and densitometry. Evidence of increased blood: CSF barrier permeability (transudation of high molecular weight proteins) was found in patients with progressive disease. The presence of oligoclonal bands was the CSF abnormality most frequently encountered.

摘要

采用聚丙烯酰胺凝胶电泳、常规实验室显微镜检查以及总蛋白和免疫球蛋白G(IgG)检测等方法,对120例多发性硬化症患者的脑脊液(CSF)进行了分析。白细胞计数与患者年龄、病程以及距上次临床复发的时间呈负相关。白细胞计数与γ球蛋白量呈正相关。发现γ球蛋白含量与残疾程度之间存在相关性。随着病程延长,只有残疾程度增加时γ球蛋白浓度才会升高。在与临床特征的相关性方面,根据IgG是通过免疫学方法还是电泳及光密度测定法进行检测,存在差异。在进行性疾病患者中发现了血脑屏障通透性增加(高分子量蛋白质渗出)的证据。寡克隆带的出现是脑脊液中最常出现的异常情况。

相似文献

1
Cerebrospinal fluid in multiple sclerosis: relationships between immunoglobulins, leucocytes and clinical features.多发性硬化症中的脑脊液:免疫球蛋白、白细胞与临床特征之间的关系
J Neurol. 1985;232(4):250-9. doi: 10.1007/BF00313789.
2
Oligoclonal bands in cerebrospinal fluid detected by PhastSystem isoelectric focusing.通过PhastSystem等电聚焦法检测脑脊液中的寡克隆带。
Clin Chem. 1990 Jan;36(1):123-5.
3
Simultaneous determination of cerebrospinal fluid oligoclonal bands and the "gamma-protein index" by agarose electrophoresis and densitometry.
Clin Chem. 1986 Jan;32(1 Pt 1):84-7.
4
[Oligoclonal immunoglobulin bands in cerebrospinal fluid in multiple sclerosis and other neurological disease].
Hua Xi Yi Ke Da Xue Xue Bao. 1986 Dec;17(4):339-42.
5
[Gamma globulin subfractions and immunoglobulin G in the cerebrospinal fluid of patients with multiple sclerosis, subacute sclerosing panencephalitis and other diseases of the nervous system].[多发性硬化症、亚急性硬化性全脑炎及其他神经系统疾病患者脑脊液中的γ球蛋白亚组分与免疫球蛋白G]
Neurol Neurochir Pol. 1987 Jul-Aug;21(4-5):344-51.
6
[Multiple sclerosis--studies of the correlations between selected parameters of immune response and the clinical course of the disease].
Neurol Neurochir Pol. 1992 Mar-Apr;26(2):164-71.
7
Cerebrospinal fluid proteins and serum immunoglobulins. Occurrence in multiple sclerosis and other neurological diseases: comparative measurement of gamma-globulin and the IgG class.脑脊液蛋白和血清免疫球蛋白。在多发性硬化症及其他神经系统疾病中的出现情况:γ球蛋白和IgG类别的比较测量
Arch Neurol. 1971 Dec;25(6):526-34. doi: 10.1001/archneur.1971.00490060060006.
8
Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.用于复发型多发性硬化症的阿沃尼单抗(干扰素β-1a)III期试验中的脑脊液异常。多发性硬化症协作研究组。
J Neuroimmunol. 1999 Jan 1;93(1-2):8-14. doi: 10.1016/s0165-5728(98)00174-x.
9
Comparison between agarose gel electrophoresis and isoelectric focusing of CSF for demonstration of oligoclonal immunoglobulin bands in neurological disorders.脑脊液琼脂糖凝胶电泳和等电聚焦用于神经系统疾病中寡克隆免疫球蛋白带显示的比较。
Acta Neurol Scand. 1978 Sep;58(3):148-56. doi: 10.1111/j.1600-0404.1978.tb02874.x.
10
The Multiple Sclerosis Cooperative Etiological Study in Italy: preliminary analysis of CSF findings.意大利多发性硬化协作病因学研究:脑脊液检查结果的初步分析
Ital J Neurol Sci. 1987 Jun;Suppl 6:71-6.

引用本文的文献

1
Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis.多发性硬化症鞘内注射皮质类固醇治疗反应的预测因素
Front Neurol. 2019 Feb 22;10:132. doi: 10.3389/fneur.2019.00132. eCollection 2019.
2
Patterns of blood-brain barrier impairment and clinical features in multiple sclerosis.多发性硬化症中血脑屏障损伤模式及临床特征
J Neurol Neurosurg Psychiatry. 1993 Apr;56(4):356-60. doi: 10.1136/jnnp.56.4.356.
3
Cerebrospinal fluid.脑脊液

本文引用的文献

1
Current trends in multiple sclerosis research.多发性硬化症研究的当前趋势。
Immunol Today. 1981 May;2(5):87-93. doi: 10.1016/0167-5699(81)90038-4.
2
Quantitative estimation of the albumin and gamma globulin in normal and pathologic cerebrospinal fluid by immunochemical methods.通过免疫化学方法对正常和病理性脑脊液中的白蛋白和γ球蛋白进行定量估计。
Am J Med. 1948 May;4(5):653-62. doi: 10.1016/s0002-9343(48)90389-1.
3
AN ELECTROPHORETIC STUDY OF THE PROTEIN COMPONENTS IN CEREBROSPINAL FLUID AND THEIR RELATIONSHIP TO THE SERUM PROTEINS.
J Neurol Neurosurg Psychiatry. 1995 Oct;59(4):349-57. doi: 10.1136/jnnp.59.4.349.
4
Cell count and ratio of helper/inducer to suppressor/cytotoxic T-cells in the cerebrospinal fluid of patients with multiple sclerosis.多发性硬化症患者脑脊液中辅助/诱导性T细胞与抑制/细胞毒性T细胞的细胞计数及比例
J Neurol. 1989 Oct;236(7):424-6. doi: 10.1007/BF00314904.
5
Fluids of the brain and the pathogenesis of MS.脑积液与多发性硬化症的发病机制
Neurochem Res. 1992 Sep;17(9):901-5. doi: 10.1007/BF00993266.
脑脊液中蛋白质成分的电泳研究及其与血清蛋白质的关系
J Clin Invest. 1942 Sep;21(5):571-7. doi: 10.1172/JCI101335.
4
The cerebrospinal fluid in multiple sclerosis.多发性硬化症中的脑脊液。
Res Publ Assoc Res Nerv Ment Dis. 1950;28:428-39.
5
The correlation between the state of the cerebrospinal fluid and the clinical picture in disseminated sclerosis.弥漫性硬化症中脑脊液状态与临床表现之间的相关性。
Acta Med Scand. 1951;139(2):153-63.
6
PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.多发性硬化症治疗的实验性试验问题:多发性硬化症治疗实验性试验评估小组报告
Ann N Y Acad Sci. 1965 Mar 31;122:552-68. doi: 10.1111/j.1749-6632.1965.tb20235.x.
7
FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS.关于多发性硬化症残疾评估的进一步说明及量表修改
Neurology. 1965 Jul;15:654-61. doi: 10.1212/wnl.15.7.654.
8
BLOOD-BRAIN BARRIER DAMAGE IN MULTIPLE SCLEROSIS SUPRAVITAL TEST-OBSERVATIONS.多发性硬化症中超活染色试验观察的血脑屏障损伤
Acta Neurol Scand Suppl. 1964;40:SUPPL 10:21-4. doi: 10.1111/j.1600-0404.1964.tb04718.x.
9
The differential diagnosis of neurological diseases by fractionating electrophoretically the CSF gamma-globulins.通过对脑脊液γ球蛋白进行电泳分离来鉴别诊断神经疾病。
J Neurochem. 1960 Aug;6:51-6. doi: 10.1111/j.1471-4159.1960.tb13448.x.
10
Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains.从多发性硬化症和亚急性硬化性全脑炎患者大脑中洗脱的IgG的等电聚焦。
Nature. 1980 Sep 25;287(5780):335-7. doi: 10.1038/287335a0.